Invest and Sell Egenesis Stock

Q: How to sell Egenesis stock?

If you hold private company shares of Egenesis - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Egenesis stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Enterprise Value

Access Egenesis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Egenesis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Egenesis stock FAQs

Can you buy Egenesis stock?

As Egenesis is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Egenesis, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Egenesis stock?

To invest in a private company like Egenesis through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Egenesis stock?

Yes, you may be able to sell your Egenesis stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Egenesis stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Egenesis stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Egenesis a public company?

No, Egenesis is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Egenesis’ stock price?

Egenesis is a privately held company and therefore does not have a public stock price. However, you may access Egenesis’ private market stock price with Forge Data.

What is Egenesis’ stock ticker symbol?

Egenesis does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Forbes 03/27/2024

The Startup Behind The First Pig-Human Kidney Transplant Is Targeting Hearts And Livers Next

A gene-edited kidney was transplanted into a patient with eGenesis's technology.

eGenesis Press 03/21/2024

eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient

A pig kidney was transplanted into an adult male by eGenesis.

Yahoo Finance 10/26/2023

eGenesis Presents Preclinical Data Demonstrating Recipient Survival and Compatibility with Genetically Engineered Porcine Kidneys at 2023 IPITA-IXA-CTRMS Joint Conference

eGenesis, a biotechnology company, has presented preclinical data on genetically engineered porcine kidneys demonstrating recipient survival and compatibility. The data was presented at the 2023 IPITA-IXA-CTRMS Joint Conference. The company is aiming to develop human-compatible organs for organ transplant, addressing the shortage of organs available for transplant.

Scientific American 10/11/2023

Monkeys with Transplanted Pig Kidneys Live for Up to Two Years or More

The biotech company eGenesis has conducted a study where genetically engineered pig kidneys were successfully transplanted into monkeys, with some recipients surviving for over two years. With this data, eGenesis aims to convince regulators to approve human clinical trials. The U.S. FDA requires at least one-year survival of xenografts in nonhuman primates before approving clinical studies.

Egenesis Stock

Register To Buy and Sell Shares